Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01
-
Shares outstanding
-
315,976,000
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
97,368,876
-
Shares change
-
+665,773
-
Total reported value, excl. options
-
$301,754,108
-
Value change
-
+$4,217,184
-
Put/Call ratio
-
38.1%
-
Number of buys
-
56
-
Number of sells
-
-63
-
Price
-
$3.10
Significant Holders of Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) as of Q2 2023
153 filings reported holding AMRX - Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 as of Q2 2023.
Amneal Pharmaceuticals, Inc. - Class A Common Stock, par value $0.01 (AMRX) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 97,368,876 shares
of 315,976,000 outstanding shares and own 30.8% of the company stock.
Largest 10 shareholders include Fosun International Ltd (21,521,301 shares), VANGUARD GROUP INC (13,135,701 shares), TPG GP A, LLC (12,328,767 shares), BlackRock Inc. (8,007,996 shares), Eversept Partners, LP (5,265,251 shares), NEUBERGER BERMAN GROUP LLC (3,747,939 shares), Rubric Capital Management LP (2,601,379 shares), STATE STREET CORP (2,230,737 shares), GEODE CAPITAL MANAGEMENT, LLC (2,194,991 shares), and AQR CAPITAL MANAGEMENT LLC (2,156,242 shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.